What Is Wrong With This Picture?
By Ed Silverman // November 10th, 2008 // 11:50 am
Two months ago, Hawthorn Pharmaceuticals launched Zamicet, an oral solution approved by the FDA to treat moderate to moderately severe pain for children two years and older. Zamicet, which contains hydrocodone bitartrate and acetaminophen, is also a controlled substance and is listed as a Schedule III drug, which means it is highly addictive (see prescribing info).
Yet, this little boy does not appear to be in pain. Rather than lying on a mat, holding a broken arm after receiving a killer karate kick, he appears to be jumping for joy after winning his match. So what might the message be? Perhaps Zamicet should be kept in a handy spot in the medicine cabinet in the event of any injury? This is subtle, no doubt. But we wonder about the targeted market.